Global Novel Drug Delivery Systems (NDDS) Market Trajectory & Analytics Report 2020: U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 19.3% CAGR

Dublin, Sept. 24, 2020 (GLOBE NEWSWIRE) -- The "Novel Drug Delivery Systems (NDDS) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Novel Drug Delivery Systems (NDDS) estimated at US$7.7 Billion in the year 2020, is projected to reach a revised size of US$27.2 Billion by 2027, growing at a CAGR of 19.7% over the period 2020-2027.

Nanoparticles, one of the segments analyzed in the report, is projected to record 19% CAGR and reach US$23.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Embolization Particles segment is readjusted to a revised 24.7% CAGR for the next 7-year period.

The U. S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 19.3% CAGR

The Novel Drug Delivery Systems (NDDS) market in the U. S. is estimated at US$2.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2027 trailing a CAGR of 19.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.4% and 16.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

• Abbott Laboratories

• AstraZeneca PLC

• Bayer HealthCare Pharmaceuticals

• F. Hoffmann-La Roche AG

• GlaxoSmithKline PLC

• Johnson & Johnson

• Merck & Co., Inc.

• Novartis International AG

• Pfizer, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares

• Novel Drug Delivery Systems (NDDS) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

• Novel Drug Delivery Systems (NDDS) Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027

• Novel Drug Delivery Systems (NDDS) Market Share Shift across Key Geographies Worldwide: 2020 VS 2027

• Nanoparticles (Segment) World Market by Region/Country in US$ Million: 2020 to 2027

• Nanoparticles (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027

• Embolization Particles (Segment) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027

• Embolization Particles (Segment) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

• Market Facts & Figures

• Novel Drug Delivery Systems (NDDS) Market Share (in %) by Company: 2019 & 2025

• Market Analytics

• Novel Drug Delivery Systems (NDDS) Market Estimates and Projections in US$ Million by Segment: 2020 to 2027

• Novel Drug Delivery Systems (NDDS) Market Share Breakdown by Segment: 2020 VS 2027

IV. COMPETITION

• Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/rv7iv1

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900